impairs ventricular relaxation; changes that further alter heart anatomy. Abnormal ventricular relaxation impedes atrial emptying of blood, which can passively stretch these thin-walled chambers and cause atrial dilation, a prevalent feature of the hypertrophic heart.
myocytes that characterize the normal myocardium (Figure 2A) becomes distorted by hypertrophic growth of the myocytes, which can produce enlarged and bizarrely shaped myocytes as well as disorientation (oblique or perpendicular alignment) of adjacent cells ( Figure 2B ). These findings, collectively termed myocyte disarray, can be focal and juxtaposed beside normal appearing myocardium or can be widespread throughout the ventricle. With premature death of hypertrophic myocytes, the cardiac fibroblasts and associated extracellular matrix increase (often referred to as "replacement" fibrosis) symptoms of shortness of breath (dypsnea) and chest pain (angina) due to impaired diastolic relaxation of the diomyopathy have been defined, genetic mapping studhypertrophic heart (Spirito et al., 1997). In addition, paies indicate this disorder will similarly exhibit substantial tients are at risk for heart failure, atrial and ventricular inter-and intragenic heterogeneity. Restrictive cardioarrhythmias, and sudden death. In the United States, myopathy remains an enigma; neither disease loci nor unrecognized hypertrophic cardiomyopathy is the most mutated genes have been discovered to cause this rarer common cause for sudden death in athletes. type of cardiomyopathy.
Diagnosis of hypertrophic cardiomyopathy is made The importance of identifying precise genetic causes by two-dimensional echocardiography, a noninvasive for cardiomyopathies may extend beyond the molecular cardiac imaging technique that reveals the extent and insights into these specific maladies. With the recent distribution of hypertrophy and delineates cardiac condevelopment and analyses of genetically engineered tractile function. Echocardiograms from a large populamodels of human cardiomyopathy mutations comes the tion of young individuals have estimated the incidence of opportunity to define critical molecules and pathways hypertrophic cardiomyopathy to be 1 in 500 individuals that participate in cardiac remodeling. Since similar pat-(Maron et al., 1995). The wide-spread use of echocarditerns of cardiac remodeling occur in response to more ography has not only confirmed autosomal dominant prevalent, acquired cardiovascular diseases, mechanistransmission of disease, it has identified age-dependent tic insights derived from the study of genetic disorders penetrance of the disease and documented marked varimay be relevant to a wide range of heart conditions that ation in the extent and distribution of the hypertrophy. remodel the heart and contribute to heart failure. myosin binding protein C genes were encoded at these As a consequence of hypertrophy, the left ventricular loci, led to the conclusion that hypertrophic cardiomyopchamber volumes are diminished, resulting in the apathy resulted from defects in cardiac sarcomere proteins pearance of a muscle-bound heart ( Figure 1A ). Histopa-(for a review, see Seidman and Seidman, 2000) . Mutathology in hypertrophic cardiomyopathy can be striktions in cardiac actin (Mogensen et al., 1999) , troponin I (Kimura et al., 1997), the essential and regulatory myosin ingly abnormal. The highly registered alignment of Pi, force is generated (termed the power stroke), and the initial unbound conformation of myosin is restored. . Transmission of force generated by the sarcomere to the myocyte cytoskeleton occurs through a complex of molecules including cardiac myosin binding protein C, titin, dystrophin, and associated sarcoglycan peptides (Schiaffino and Reggiani, 1996). These provide elasticity to the cell and may also modulate contractile force.
Molecular genetic studies of familial hypertrophic cardiomyopathy help to explain the clinical diversity of this
There are several different mechanisms by which mutations in genes encoding sarcomere proteins could produce hypertrophic cardiomyopathy. Some dominant gene mutations inactivate an allele, resulting in a reduced amount of functional protein (haploinsufficiency), while other dominant gene mutations create a mutant protein that interferes with normal protein function (dominant negative) or that has a novel function. Most Other defects occur in residues that comprise a flexible enzymatic activity for ATP hydrolysis and sites for bindfulcrum in myosin, or that bind myosin light chains. The ing actin; as such, the myosin head is often considered absence of clear clustering of human hypertrophic dethe motor in sarcomeres. Contraction is initiated when fects within any one functional domain of myosin may cytosolic calcium rises and binds the troponin complex be interpreted to indicate that a change in any of the (composed of subunits C, T, and I) and ␣ tropomyosin. specific biophysical events during muscle contraction Calcium releases troponin I inhibition of actin-myosin could produce cardiac hypertrophy. However, more reinteractions, and promptly actin becomes tightly bound cent studies of myosin mutations that cause dilation to the myosin head. ATP then binds myosin and alters (described below) suggest otherwise. the conformation of the actin binding sites within myoThe construction of animal models of mutated myosin, so that head domain is displaced along the thin sins identified from patients with hypertrophic cardiomyopathy has allowed more rigorous assessment of filament. With ATP hydrolysis and release of ADP and ., 2000b) . The enexhibited enhanced actin-activated myosin ATPase activity, increased generated force, and accelerated actin hanced hypertrophy and worsened histopathology induced by this agent could be blocked by coadministration filament sliding, all consistent with a gain in myosin functions. An appealing aspect of these findings is that of calcium-channel inhibitors. While the precise signaling pathways that account for these observations remain unthey suggest a molecular mechanism for the supra normal cardiac performance that is often evident in humans known, these data imply that myosin mutations cause a fundamental dysregulation of calcium. with hypertrophic cardiomyopathy. It is noteworthy that the consequences of a gain in myosin function would Ca 2ϩ concentrations are stringently controlled in myocytes (reviewed in Mackrill, 1999), because of the intinot be entirely beneficial. Although there was an improvement in motor performance of individual myosin mate role that this ion plays in myofilament contraction. Variation in calcium concentrations during relaxation Arg403Gln molecules, heterogeneity of mutant and wildtype myosin proteins within the sarcomere would likely and contraction is precisely orchestrated through subcellular compartmentalization of this ion in the saruncouple the mechanical coordination that normally occurs between myosin heads. In addition, enhanced coplasmic reticulum and sarcomere ( Figure 5 ). Ca 2ϩ crosses the myocyte plasma membrane through L-type ATPase activity would result in higher levels of energy consumption by the hypertrophic heart. If energy con-(dihydropyridine) Ca 2ϩ channels, which are in close proximity to intracellular ryanodine receptors that span sumption exceeded energy supply, hypertrophic myocytes might die prematurely. And since myocytes can the sarcoplasmic reticulum. Calcium induces activation of ryanodine receptors, resulting in rapid release of senot replicate, proliferation of cardiac fibroblast would ensue and cause replacement fibrosis, a well-recogquestered calcium from the sarcoplasmic reticulum to the cytoplasm, which triggers sarcomere contraction. nized histopathologic feature of this disease. While at present it is unknown whether a gain in function is unique Calcium is removed from the sarcomere and cytoplasm after contraction through the activity of a calciumto the Arg403Gln mutation in myosin, or occurs with other defects, these unexpected data indicate the imATPase pump (SERCA), which restores Ca 2ϩ to the sarcoplasmic reticulum. In addition, the sarcoplasmic reticportance of biophysical information for an appropriate understanding of the mechanism by which hypertrophic ulum contains muscle-specific Ca 2ϩ binding proteins, including calsequestrin and calpactin, which serve to cardiomyopathy mutations cause disease.
An important corollary to the conclusion that sarcobuffer free calcium. One mechanism by which the Arg403Gln mutation mere mutations alter the molecular processes of muscle contraction is that these events also activate pathways could produce dysregulation of subcellular calcium concentrations might be through altered sarcomere Ca 2ϩ for myocyte growth. Although little is currently known about signaling pathways that link sarcomere force prorequirements. If by perturbing the biophysical events of contraction, this mutation chronically increased calcium duction to myocyte growth, and ultimately cardiac hypertrophy, evidence implicates a critical role for calcium contained in the sarcomere, a relative depletion of this ion might occur within the sarcoplasmic reticulum. Calin signal transduction. Studies of nongenetic causes of Mestroni et al., 1999) . These include cardiac features as well as noncardiac manifestations (Table 1) .
to be through ineffectual propagation of force from the sarcomere to the extracellular matrix. Deficits in force Several genetic loci have been defined that cause electrical physiologic abnormalities (atrial-ventricular contransmission would presumably signal compensatory responses in the myocyte and heart that result in cardiac duction delay) that arise not as a consequence of ventricular dilation and dysfunction, but in advance of remodeling (myocyte hypertrophy and ventricular dilation) in an attempt to augment systolic function. An altercardiac remodeling. Muscular dystrophy is another prevalent associated phenotype (Mestroni et al., 1999) , native mechanism has been suggested from comparison of mice engineered to lack either the muscle-specific ␣ which may result when defects perturb cellular processes that are common to all striated muscle. In other subunit or the more broadly expressed ␦ subunit of this sarcoglycan complex (Cora-Vazquez et al., 1999). While instances, an associated clinical manifestation is seemingly unexplainable, such as a form of sensorineural each mutation produces muscular dystrophy in mice, only the ␣ sarcoglycan-deficient mice developed dilated hearing loss that precedes by several decades the onset of dilated cardiomyopathy (Schonberger et al., 2000) .
cardiomyopathy. Surprisingly, the inciting event for heart disease was not an intrinsic defect in myocyte Discovery of the molecular basis for these usual phenotypes may therefore provide opportunity to learn about structure or function but rather malformations within the coronary artery tree. Loss of the ␣ sarcoglycan altered previously unrecognized aspects of myocyte biology.
Identification of genetic causes for dilated cardiomythe cytoskeletal integrity of vascular smooth muscle sufficiently to perturb vascular architecture and diminish opathy has indicated several potential mechanisms by which heart muscle can fail. Effective muscle contraccoronary artery blood flow. While these findings are unlikely to be directly relevant to most forms of dilated tion requires force generation by the sarcomere and force transmission to the cytoskeleton and the extracelcardiomyopathy, recognition of an ischemic component in even a subset of dystrophin-sarcoglycan muscle dislular matrix. Although early discoveries suggested that ineffectual force transmission was the essential deficit ease in humans will have important therapeutic implications. in myocyte function that caused dilated cardiomyopathy A better understanding of the role that structural protions that cause hypertrophic cardiomyopathy (Figure 4 , blue spheres), the location of these defects (red spheres) teins play in myocyte biology has sparked consideration of additional molecules as candidates for mutations that predicts that force production by the contractile apparatus may be diminished. cause cardiac and skeletal muscle disease. Multiple muscle-specific proteins of unknown function reside Deficits in sarcomere force production may also be the consequence of the cardiac troponin T mutation within the cytoplasm. Targeted disruption of murine genes that encode the actin-associated cytoskeletal that causes dilated cardiomyopathy. In two unrelated families, a deletion of one of five highly conserved lysine muscle LIM protein (Arber et al., 1997) or the intermediate filament protein desmin that connects sarcomere to codons (⌬Lys210) was identified. This deletion is likely to weaken complementary ionic interactions with a ring plasma membrane (Milner et al., 1996) , disrupted normal myocyte architecture and caused myocyte degeneraof acidic residues located on the surface of cardiac troponin C (Filatov et al., 1999) , the binding partner of tion and death. In the hearts of mutant mice, these events caused dilated cardiomyopathy. Such findings troponin T. Because the troponin complex regulates calcium-stimulated actin-myosin ATPase activity, defects prompted analyses of desmin as a candidate cause of human myopathies that affect both skeletal and heart in troponin T could diminish energy production for actinmyosin detachment and reattachment, and thereby remuscles, and subsequently, desmin mutations have been reported (Goldfarb et al., 1998; Li et al., 1999) . duce contractile force within the sarcomere. The demonstration that allelic mutations in cardiac Deficits in this protein may render myocytes more susceptible to mechanical stresses associated with conactin, ␤ cardiac myosin heavy chain, and cardiac troponin T produce either hypertrophic or dilated cardiotraction. Weakened myocytes and/or premature death of these cells could presumably reduce contractile funcmyopathy might be interpreted to indicate that other genetic factors influence development of either the hytion and trigger pathways for cardiac remodeling.
A candidate gene strategy also revealed that cardiac pertrophic or dilated pathology. In hamsters, a single mutation produces either hypertrophic or dilated cardioactin mutations are a rare cause of autosomal dominant dilated cardiomyopathy that occurs without any other myopathy in two related strains, presumably due to the influence of modifying factors that are different in these associated clinical phenotypes ( In contrast to cardiac actin mutations, recent discovflanking lysine residues that may also participate in ionic interactions with troponin C that are affected in dilated eries of mutations in other genes suggest that deficits in force production also result in ventricular dysfunction cardiomyopathy. Collectively, these data indicate that the hypertrophic or dilated pattern of cardiac remodeland dilation. Mutations have been identified in ␤ cardiac myosin heavy chain and cardiac troponin T (Kamisago ing is a direct consequence of a specific mutation. The finding that both hypertrophic and dilated cardioet al., 2001) that cause early onset heritable dilated cardiomyopathy. As observed in patients with cardiac actin myopathy can be caused by sarcomere protein mutations also raises the question of whether there are two mutations, patients with dilated cardiomyopathy due to ␤ cardiac myosin heavy chain or cardiac troponin T distinct programs that remodel the heart, or whether these different morphologies reflect gradations of a sindefects had neither additional cardiac nor extracardiac findings. These data also imply that the other constituent gle pathway. A single pathway model might predict that the extent of remodeling mirrors the severity of sarcoproteins of the sarcomere (Figure 3 and Schiaffino and Reggiani, 1996) are excellent candidates for mutations mere dysfunction: mild deficits could result in hypertrophy, while more severe dysfunction that remained unthat cause isolated dilated cardiomyopathy.
Atomic structures and biochemical information have compensated despite hypertrophic growth might trigger myocyte death and eventually result in cardiac dilation. been useful for inferring the functional consequences of dilated cardiomyopathy mutations in myosin heavy Studies of genetically engineered mice support the model for a single progressive program; mice heterozygous for chain and troponin T. A missense mutation (Ser532Pro) in ␤ cardiac myosin perturbs a highly conserved ␣ helical sarcomere mutations develop hypertrophic cardiomyopathy (Geisterfer-Lowrance et al., 1996), whereas hostructure located in the lower 50 kDa domain, that forms the actin binding domain known nuclear processes may each trigger dilated remod-2000) is severe cardiac hypertrophy. The absence of eling pathways that ultimately cause the heart to fail. Deventricular dilation in these human hearts with twice the spite the multiplicity of inciting mechanisms, the rather dose of mutant sarcomere proteins is consistent with singular cardiac response to these diverse events may distinct programs that remodel the heart into either hyindicate that a few molecules are critical for monitoring pertrophic or dilated morphologies. myocyte malfunction. Given the exquisite regulation of In addition to deficits of force production and force calcium in various compartments throughout the cardiac transmission, human genetic studies have uncovered cycle, and increasing evidence that calcium dysregulation unexpected causes for dilated cardiomyopathy, particuoccurs in hypertrophic cardiomyopathy, this ion may also larly those that occur in association with conduction be a critical factor in remodeling the heart into a dilated system disease. Several large kindreds described with morphology ( Figure 5 ). Studies of genetically engineered this disorder exhibit progressive prolongation of the normouse models for dilated cardiomyopathy support this mal delay in electrical activation of the atrial and ventrichypothesis. The absence of the actin-associated cytoskelular chambers; after many years of conduction system etal muscle LIM protein results in heart failure in mice disease, the myocardium dilates and heart failure en- It is almost inevitable that other human mutations that reassembly of the nuclear membrane after cell division.
can cause cardiomyopathy will be discovered in the near However, the function of lamins in nondividing cells such future. Indeed, many genetic loci are known to cause dias cardiac myocytes is largely unknown. lated cardiomyopathy, but relatively few disease genes A further puzzling aspect to the biology of lamins have been identified. Thus, our current understanding of is the phenotype associated with different mutations. the molecular basis for these disorders is really quite limMissense codons that cause cardiomyopathy and conited. Additional new discoveries of human gene mutations duction disease but not skeletal muscle disease show that remodel the heart can be expected to define other some clustering in the proximal helical rod domains of inciting events that may perturb unrecognized cellular prothe A and C isoforms. However, null and missense cesses to trigger programs that restructure heart mormutations identified in the central helical rod domain phology and cause cardiac failure. An immediate clinical cause juvenile-onset skeletal muscular dystrophies (aubenefit from the discovery of human gene mutations is tosomal dominant Emery-Dreifuss muscular dystrophy, early and accurate diagnosis. While this is sometimes Bonne et al., 1999; limb girdle muscular dystrophy, viewed to be of limited value, the true worth is perhaps Muchir et al., 2000) . Still other mutations in the carboxyl best considered in light of epidemiologic data that inditerminus of lamins A and C cause another disorder, cates the substantial hereditary component to both carfamilial partial lipodystrophy (Dunnigan type; Shackdiomyopathy and heart failure. Improved recognition leton et al., 2000), which is characterized by adipocyte and intervention in advance of heart failure has considerdegeneration and insulin-resistant diabetes. The relaable merit for reducing the serious morbidity and mortaltively distinct location of these disease-specific mutaity associated with these disorders. tions may imply that particular domains of lamin are Continued development and study of genetically engicritical for protein-protein interactions that might conneered models of cardiomyopathies enables study of vey tissue-specificity to lamin functions. Alternatively, the integrative physiology of multiple organ systems that lamin mutations might simply impair the structural integappear to participate in remodeling processes of the rity of the nucleus, and cause premature cell death.
heart and may ultimately lead to a clearer definition of Since the mechanical stresses that are imposed on the molecular pathways affected by gene mutations. Elucinucleus in contracting cells are likely to be greater than dation of these pathways leading from mutant protein those in stationary cells, myocytes might be particularly vulnerable to lamin mutations. Further elucidation of the to disease will lead to better understanding of myocyte 
